リンパ腫アトラス 第5版

出版社: 文光堂
著者:
発行日: 2018-10-01
分野: 臨床医学:基礎  >  臨床病理学
ISBN: 9784830604799
電子書籍版: 2018-10-01 (第5版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
発送目安:4~8営業日

26,400 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

26,400 円(税込)

商品紹介

1981年の初版(書名:新分類による 悪性リンパ腫アトラス)刊行以来,絶大な支持を誇る「リンパ腫アトラス」の第5版.WHO分類第4版改訂版(2017)をベースに,近年進歩が著しい免疫組織化学・分子遺伝学的所見を含め,最新の知見を盛り込んだ.また,WHO分類が対象としていない反応性・境界領域病変も取り上げている.旧版同様,精選された組織・細胞写真は,他書にはみない大きさで多数掲載.初学者,専門家を問わず,病理医・リンパ腫診療に携わる医師,必携の書.

目次

  • 表紙
  • 執筆者一覧
  • 初版の序
  • 目次
  • [ 総論 ]
  • 1 リンパ腫分類の進化
  • 2 リンパ組織の形態と機能
  • 3 免疫組織化学 ( immunohistochemistry : IHC ) とin situ hybridization ( ISH )
  • 4 フローサイトメトリー
  • 5 分子生物学
  • 6 リンパ節ならびに節外臓器の取り扱いかた
  • 7 リンパ腫の臨床
  • 8 リンパ腫の疫学
  • 9 リンパ腫のゲノム異常
  • [ 各論 ]
  • I 前駆リンパ系腫瘍
  • 1 Bリンパ芽球性白血病 / リンパ腫・非特定型
  • 2 複数例でみられる遺伝子異常を伴うBリンパ芽球性白血病 / リンパ腫
  • 3 Tリンパ芽球性白血病 / リンパ腫
  • 4 NKリンパ芽球性白血病 / リンパ腫
  • II 成熟B細胞腫瘍
  • 1 慢性リンパ球性白血病 / 小リンパ球性リンパ腫
  • 2 B細胞前リンパ球性白血病
  • 3 脾辺縁帯リンパ腫
  • 4 有毛細胞白血病
  • 5 脾B細胞リンパ腫 / 白血病・分類不能群
  • 6 リンパ形質細胞性リンパ腫
  • 7 IgM型意義不明の単クローン性ガンマグロブリン血症
  • 8 重鎖病
  • 9 形質細胞腫瘍
  • 10 粘膜関連リンパ組織型節外性辺縁帯リンパ腫 ( MALTリンパ腫 )
  • 11 節性辺縁帯リンパ腫
  • 12 濾胞性リンパ腫
  • 13 小児型濾胞性リンパ腫
  • 14 IRF4再構成を伴う大細胞型B細胞リンパ腫
  • 15 原発性皮膚濾胞中心リンパ腫
  • 16 マントル細胞リンパ腫
  • 17 びまん性大細胞型B細胞リンパ腫・非特定型
  • 18 T細胞 / 組織球豊富型大細胞型B細胞リンパ腫
  • 19 原発性中枢神経系びまん性大細胞型B細胞リンパ腫
  • 20 原発性皮膚びまん性大細胞型B細胞リンパ腫・下肢型
  • 21 EBV陽性びまん性大細胞型B細胞リンパ腫・非特定型
  • 22 EBV陽性粘膜皮膚潰瘍
  • 23 慢性炎症関連びまん性大細胞型B細胞リンパ腫
  • 24 リンパ腫様肉芽腫症
  • 25 原発性縦隔 ( 胸腺 ) 大細胞型B細胞リンパ腫
  • 26 血管内大細胞型B細胞リンパ腫
  • 27 ALK陽性大細胞型B細胞リンパ腫
  • 28 形質芽球性リンパ腫
  • 29 原発性体腔液リンパ腫
  • 30 HHV8関連リンパ増殖異常症
  • 31 バーキットリンパ腫 ( 11q異常を伴うバーキット様リンパ腫を含む )
  • 32 高悪性度B細胞リンパ腫
  • 33 びまん性大細胞型B細胞リンパ腫と古典的ホジキンリンパ腫の中間的特徴を伴うB細胞リンパ腫・分類不能型
  • III 成熟TおよびNK細胞腫瘍
  • 1 T細胞前リンパ球性白血病
  • 2 T細胞大型顆粒リンパ球性白血病
  • 3 慢性NK細胞リンパ増殖異常症
  • 4 急速進行性NK細胞白血病
  • 5 小児EBV陽性T細胞およびNK細胞リンパ増殖性疾患
  • 6 成人T細胞白血病 / リンパ腫
  • 7 節外性NK / T細胞リンパ腫・鼻型
  • 8 腸T細胞リンパ腫
  • 9 肝脾T細胞リンパ腫
  • 10 皮下脂肪織炎様T細胞リンパ腫
  • 11 菌状息肉症
  • 12 セザリー症候群
  • 13 原発性皮膚CD30陽性T細胞リンパ増殖異常症
  • 14 原発性皮膚末梢性T細胞リンパ腫・稀少病型
  • 15 末梢性T細胞リンパ腫・非特定型
  • 16 血管免疫芽球性T細胞リンパ腫および他のT濾胞ヘルパー細胞起源節性リンパ腫
  • 17 未分化大細胞型リンパ腫・ALK 陽性型
  • 18 未分化大細胞型リンパ腫・ALK 陰性型
  • 19 乳房インプラント関連未分化大細胞リンパ腫
  • IV ホジキンリンパ腫
  • 1 結節性リンパ球優位型ホジキンリンパ腫
  • 2 古典的ホジキンリンパ腫
  • V 免疫不全関連リンパ増殖異常症
  • 1 原発性免疫異常症に伴うリンパ増殖異常症
  • 2 HIV感染に伴うリンパ腫
  • 3 移植後リンパ増殖異常症
  • 4 その他の医原性免疫不全関連リンパ増殖異常症
  • VI 組織球性および樹状細胞腫瘍
  • 1 組織球性肉腫
  • 2 ランゲルハンス細胞由来腫瘍
  • 3 不確定樹状細胞腫瘍
  • 4 指状嵌入樹状細胞肉腫
  • 5 濾胞樹状細胞肉腫
  • 6 線維芽細胞性細網細胞腫瘍
  • 7 播種性若年性黄色肉芽腫
  • 8 エルドハイム・チェスター病
  • VII 境界病変ならびにリンパ腫と鑑別を要する疾患
  • A 境界病変
  • 1 自己免疫疾患におけるリンパ節症
  • 2 キャッスルマン病, TAFRO症候群, IgG4関連疾患
  • 3 胚中心進展性異形成
  • 4 炎症性偽腫瘍
  • 5 Rosai - Dorfman病
  • 6 リンパ腫様胃症 / NK細胞腸症
  • B 反応性病変
  • 1 皮膚病性リンパ節症
  • 2 薬剤性リンパ節症
  • 3 組織球性壊死性リンパ節炎 ( 菊池病 )
  • 4 木村病
  • 5 川崎病
  • C 感染症
  • 1 細菌・真菌性ならびに原虫性リンパ節疾患, およびサルコイドーシス
  • 2 ウイルス性リンパ節炎 ( 1 ) 伝染性単核症
  • 3 ウイルス性リンパ節炎 ( 2 ) その他のウイルス感染症
  • D その他の腫瘍
  • 1 骨髄性肉腫
  • 2 肥満細胞症 ( 肥満細胞腫瘍 )
  • 3 芽球性形質細胞様樹状細胞腫瘍
  • 4 リンパ腫の鑑別対象となる固形腫瘍
  • コラム1 low grade B - cell lymphoma, unclassifiable
  • コラム2 異型リンパ過形成 atypical lymphoid hyperplasia
  • 診断に有用なパラフィン切片に使用可能な主な抗体
  • 本文中で用いられている主な略語
  • 文献
  • 索引
  • 奥付

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[ 総論 ]

P.2 掲載の参考文献
1) Swerdlow SH, Campo E, Pileri SA, et al. : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer, 2017
2) 森茂郎 : リンパ腫分類の進化. リンパ腫アトラス 改題・改訂第4版, 2014
P.12 掲載の参考文献
1) Yoshino T, Kondo E, Cao L, et al. : Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83 : 1856-1861, 1994
2) Jaffe ES, Harris NL, Stein H, et al. eds. : Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Pathology and Genetics, IARC Press, 2001
3) 中峯寛和, 難波紘二 : リンパ球の分化成熟・リンパ節の基本構築と各種反応パターン. 新悪性リンパ腫アトラス, 文光堂, 2, 2000
4) Stein K, Hummel M, Korbjuhn P, et al. : Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. Blood 94 : 2800-2808, 1999
5) Conconi A, Bertoni F, Pedrinis E, et al. : Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. Blood 98 : 781-786, 2001
P.20 掲載の参考文献
2) Sarkozy C, Traverse-Glehen A, Coiffier B : Double-hit and double-protein-expression lymphomas : aggressive and refractory lymphomas. Lancet Oncol 16 : e555-e567, 2015
3) Georgiou K, Chen L, Berglund M, et al. : Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas. Blood 127 : 3026-3034, 2016
P.26 掲載の参考文献
1) Melamed MR, Lindomo T, Mendelsohn ML, et al. eds. : Flow Cytometry and Sorting, Wiley-Liss, 1990
2) Swerdlow SH, Campo E, Harris NL, et al. eds. : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., IARC Press, 2017
3) 一迫玲 : 免疫学的表現型解析-免疫組織化学とフローサイトメトリー-. 内科 102 : 239-246, 2008
4) 一迫玲 : 悪性リンパ腫 : 診断と治療の進歩-細胞表面マーカー-. 日内会誌 97 : 41-48, 2008
5) 一迫玲 : フローサイトメトリーによる悪性リンパ腫の診断. 血腫瘍 59 : 642-651, 2009
6) 飛内賢正, 他編 : 悪性リンパ腫治療マニュアル (改訂第3版), 南江堂, 2009
9) Ginaldi L, De Martinis M, D'Ostilio A, et al. : Altered lymphocyte antigen expressions in HIV infection : a study by quantitative flow cytometry. Am J Clin Pathol 108 : 585-592, 1997
P.32 掲載の参考文献
1) Tamaru J, Hummel M, Marafioti T, et al. : Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am J Pathol 147 : 1398-1407, 1995
2) van Dongen JJ, Langerak AW, Bruggemann M, et al. : Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations : report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 : 2257-2317, 2003
4) Karube K, Campo E : MYC alterations in diffuse large B-cell lymphomas. Semin Hematol 52 : 97-106, 2015
5) Miki T, Kawamata N, Arai A, et al. : Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood 83 : 217-222, 1994
7) Kato M, Sanada M, Kato I, et al. : Frequent inactivation of A20 in B-cell lymphomas. Nature 459 : 712-716, 2009
9) Scott DW, Gascoyne RD : The tumour microenvironment in B cell lymphomas. Nature Rev Cancer 14 : 517-534, 2014
P.41 掲載の参考文献
1) Banks PM : Technical factors in the preparation and evaluation of lymph node biopsies. Neoplastic Hematopathology, 2nd Ed., Knowles DM ed., Lippincott Williams and Wilkins, pp467-482, 2001
2) Rosai J : Lymphnode evaluation. Rosai and Ackerman's Surgical Pathology, 9th Ed., Mosby, pp1879-1887, 2004
P.45 掲載の参考文献
1) Si egel R, Miller K, Jemal A, et al. : Cancer statistics, 2018. CA Cancer J Clin 68 : 7-30, 2018
2) Hiddemann W, Longo DL, Coiffier B, et al. : Lymphoma classification- -the gap between biology and clinical management is closing. Blood 88 : 4085-4089, 1996
4) Kaplan HS, Rosenberg SA : The treatment of Hodgkin's disease. Med Clin North Am 50 : 1591-1610, 1966
9) Cheah CY, Fowler NH, Wang ML : Breakthrough therapies in B-cell non-Hodgkin lymphoma. Ann Oncol 27 : 778-787, 2016
10) Cheson BD, Horning SJ, Coiffier B, et al. : Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17 : 1244, 1999
P.52 掲載の参考文献
1) Ferlay J, Soerjomataram I, Ervik M, et al. : GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 11 [Internet], International Agency for Research on Cancer, 2013 (Available from : http://globocan.iarc.fr, accessed on 24/12/2017)
2) Bray F, Colombet M, Mery L, et al. eds. : Cancer Incidence in Five Continents, Vol. XI (electronic version), International Agency for Research on Cancer, 2017 (Available from : http://ci5.iarc.fr, accessed on 24/12/2017)
3) Jaffe ES, Harris NL, Stein H, et al. eds. : Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues, IARC Press, 2004
P.57 掲載の参考文献
2) Swerdlow S, Campo E, Harris N, et al. : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., IARC Press, 2017
5) Moffitt AB, Dave SS : Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma. J Clin Oncol 35 : 955-962, 2016
6) Woyach JA, Furman RR, Liu TM, et al. : Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. N Engl J Med 370 : 2286-2294, 2014
7) Pastore A, Jurinovic V, Kridel R, et al. : Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma : a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol 16 : 1111-1122, 2015
9) Lenz G, Wright G, Dave SS, et al. : Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359 : 2313-2323, 2008
11) Reddy A, Zhang J, Davis NS, et al. : Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell 171 : 481-494 e15, 2017

[ 各論 ]

P.66 掲載の参考文献
3) Ries LAG, Kosary CL, Hankey BF, et al. : SEER Cancer Statistics Review, 1973-1996. Bethesda, MD : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1999
4) Smith MA, Reis LA, Gunew JG, et al. : Cancer incidence and survival among children and adolescents : United States SEER program 1975-1995. Bethesda, MD : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1999
5) Sander CA, Jaffe ES, Gebhardt FC, et al. : Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol 16 : 300-305, 1992
7) Lin P, Jones D, Dorfman DM, et al. : Precursor B-cell lymphoblastic lymphoma : a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 24 : 1480-1490, 2000
8) Bernard A, Murphy SB, Melvin S, et al. : Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood 59 : 549-554, 1982
P.70 掲載の参考文献
4) Paietta E, Racevskis J, Neuberg D, et al. : Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts : results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council. Leukemia 11 : 1887-1890, 1997
5) Wiemels JL, Cazzaniga G, Daniotti M, et al. : Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354 : 1499-1503, 1999
6) Tsuzuki S, Karnan S, Horibe K, et al. : Genetic abnormalities involved in t (12 ; 21) TEL-AML1 acute lymphoblastic leukemia : analysis by means of array-based comparative genomic hybridization. Cancer Sci 98 : 698-706, 2007
7) Rubnitz JE, Wichlan D, Devidas M, et al. : Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia : a Children's Oncology Group study. J Clin Oncol 26 : 2186-2191, 2008
8) Harris MB, Shuster JJ, Carroll A, et al. : Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure : a Pediatric Oncology Group study. Blood 79 : 3316-3324, 1992
9) Raimondi SC, Pui CH, Hancock ML, et al. : Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 10 : 213-224, 1996
10) Sutcliffe MJ, Shuster JJ, Sather HN, et al. : High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia : a Children's Oncology Group (COG) initiative. Leukemia 19 : 734-740, 2005
11) Heerema NA, Raimondi SC, Anderson JR, et al. : Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes Cancer 46 : 684-693, 2007
12) Yeoh EJ, Ross ME, Shurtleff SA, et al. : Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1 : 133-143, 2002
13) Kaspers GJ, Smets LA, Pieters R, et al. : Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs : results of an in vitro study. Blood 85 : 751-756, 1995
16) Grimaldi JC, Meeker TC : The t (5 ; 14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood 73 : 2081-2085, 1989
17) Borowitz MJ, Hunger SP, Carroll AJ, et al. : Predictability of the t (1 ; 19) (q23 ; p13) from surface antigen phenotype : implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis : a Pediatric Oncology Group study. Blood 82 : 1086-1091, 1993
18) Raimondi SC, Behm FG, Roberson PK, et al. : Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t (1 ; 19). J Clin Oncol 8 : 1380-1388, 1990
19) Cytogenetic abnormalities in adult acute lymphoblastic leukemia : correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Blood 87 : 3135-3142, 1996
21) Vey N, Thomas X, Picard C, et al. : Allogeneic stem cell transplantation improves the outcome of adults with t (1 ; 19) /E2A-PBX1 and t (4 ; 11) /MLL-AF4 positive B-cell acute lymphoblastic leukemia : results of the prospective multicenter LALA-94 study. Leukemia 20 : 2155-2161, 2006
P.75 掲載の参考文献
2) Coustan-Smith E, Mullighan CG, Onciu M, et al. : Early T-cell precursor leukaemia : a subtype of very high-risk acute lymphoblastic leukaemia. Lancet 10 : 147-156, 2009
3) Inukai T, Kiyokawa N, Campana D, et al. : Clinical significance of early T-cell precursor acute lymphoblastic leukaemia : results of the Tokyo Children's Cancer Study Group Study L99-15. Br J Haematol 156 : 358-365, 2012
4) Zhang J, Ding L, Holmfeldt L, et al. : The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481 : 157-163, 2012
P.80 掲載の参考文献
1) Eli zaga FV, Oishi N : Chronic lymphocytic leukemia in Japanese in Hawaii. Hawaii Med J 36 : 169-171, 1977
2) Swerdl ow SH, Campo E, Harris NL, et al. : WHO classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., IARC Press, 2017
4) Gi ne E, Martinez A, Villamor N, et al. : Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95 : 1526-1533, 2010
5) Nakamura N, Abe M : Richter syndrome in B-cell chronic lymphocytic leukemia. Pathol Int 53 : 195-203, 2003
6) Lanasa MC, Weinberg JB : Immunologic aspects of monoclonal B-cell lymphocytosis. Immunol Res 49 (1-3) : 269-280, 2011
P.85 掲載の参考文献
1) Lens D, De Schouwer PJ, Hamoudi RA, et al. : p53 abnormalities in B-cell prolymphocytic leukemia. Blood 89 : 2015-2023, 1997
2) Lens D, Matutes E, Catovsky D, et al. : Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL). Leukemia 14 : 427-430, 2000
P.87 掲載の参考文献
1) Diebold J, Weisenburger D, MacLennan KA, et al. : Reproducibility and prognostic value of histopathological classifications of malignant lymphomas. Prolegomena for the 1st international classification proposed by WHO. Group of the non-Hodgkin's Malignant Lymphoma Classification Project. Bull Acad Natl Med 182 : 1537-1548 ; discussion 48-49, 1998
4) Kojima M, Sato E, Oshimi K, et al. : Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases. J Clin Exp Hematop 50 : 107-112, 2010
5) Salido M, Baro C, Oscier D, et al. : Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas : a multicenter study of the Splenic B-Cell Lymphoma Group. Blood 116 : 1479-1488, 2010
11) Duong Van Huyen JP, Molina T, Delmer A, et al. : Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol 24 : 1581-1592, 2000
12) Catovsky D, Matutes E : Splenic lymphoma with circulating villous lymphocytes/splenic marginalzone lymphoma. Semin Hematol 36 : 148-154, 1999
13) Ruchlemer R, Parry-Jones N, Brito-Babapulle V, et al. : B-prolymphocytic leukaemia with t (11 ; 14) revisited : a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol 125 : 330-336, 2004
14) Piris MA, Mollejo M, Campo E, et al. : A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma : the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma. Histopathology 33 : 230-239, 1998
P.91 掲載の参考文献
1) Foucar K, Falini B, Stein H : Hairy cell leukaemia. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, 226-228, 2017
2) Bouroncle BA, Wiseman BK, Doan CA : Leukemic reticuloendotheliosis. Blood 13 : 609-630, 1958
3) Golde DW, Weiss MA : Hairy cell leukemia, an historical perspective. Hairy cell leukemia, Tallman MS, Polliack A eds., Harwood academic publishers, 1-7, 2000
4) Katayama I, Finkel HE : Leukemic reticuloendotheliosis : a clinicopathologic study with review of the literature. Am J Med 57 : 115-126, 1974
6) Takeuchi H, Kayano H, Katayama I : Utility versus futility in subclassifying hairy cell leukemia in Japanese. Int J Hematol 68 : 221-225, 1998
9) Tiacci E, Trifonov V, Schiavoni G, et al. : BRAF muations in Hairy-cell leukemia. N Engl J Med 364 : 2305-2315, 2011
10) Tiacci E, Schiavoni G, Marteelli MP, et al. : Constant activation of the RAF-MEK-REK pathway as a diagnostic and therapeutic target in Hairy cell leukemia. Hematologica 98 : 635-639, 2013
11) Waterfall JJ, Arons E, Walker RL, et al. : High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Gent 46 : 8-10, 2014
12) Machii T, Tokumine Y, Inoue R, et al. : Predominance of a distinct subtype of hairy cell leukemia in Japan. Leukemia 7 : 181-186, 1993
13) 中村裕一, 茅野秀一, 掛川絵美 : 放射線治療後眼窩MALTリンパ腫患者に顕在化したhairy cell leukemia Japanese variant. 臨床血液 51 : 1674-1679, 2010
P.95 掲載の参考文献
1) Pi ri s M, Foucar K, Mollejo M, et al. : Splenic B-cell lymphoma/leukaemia, unclassifiable. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, pp229-231, 2017
3) Kanellis G, Mollejo M, Montes-Moreno S, et al. : Splenic diffuse red pulp small B-cell lymphoma : revision of a series of cases reveals characteristic clinicopathological features. Haematologica 95 : 1122-1129, 2010
4) Medeiros LJ, O'Malley DP, Caraway N, et al. : Splenic diffuse red pulp small B-cell lymphoma. AFIP Atlas of Tumor Pathology, 4th series, fascicle 25, Tumors of the Lymph Nodes and Spleen, American Registry of Pathology, pp899-904, 2017
5) Traverse-Glehen A, Verney A, Gazzo S, et al. : Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations against B-cell malignancies. Leuk Lymphoma 58 : 666-675, 2017
6) Curiel-Olmo S, Mondejar R, Almaraz C, et al. : Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood 129 : 1042-1045, 2017
7) Baseggio L, Traverse-Glehen A, Callet-Bauchu E, et al. : Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL). Hematol Oncol 29 : 47-51, 2011
8) Medeiros LJ, O'Malley DP, Caraway M, et al. : Hairy cell leukemia-variant. AFIP Atlas of Tumor Pathology, 4th series, fascicle 25, Tumors of the Lymph Nodes and Spleen, American Registry of Pathology, pp875-883, 2017
9) Matute E, Martinez-Trillos A, Campo E, et al. : Hairy cell leukemia-variant. Disease features and treatment. Best Pract Res Clin Haematol 28 : 253-263, 2015
P.99 掲載の参考文献
1) Treon SP, Xu L, Yang G, et al. : MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 367 : 826-833, 2012
2) Waldenstrom J : Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia-a new syndrome? Acta Med Scand 117 : 216-217, 1944
P.101 掲載の参考文献
1) Hunt er ZR, Yang G, Xu L, et al. : Genomics, Signaling, and Treatment of Waldenstrom Macroglobulinemia. J Clin Oncol 35 : 994-1001, 2017
P.102 掲載の参考文献
1) Cook JR, Harris NL, Isaacson PG, et al. : Heavy chain diseases. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, 237-240, 2017
3) Lee MT, Parwani A, Humphrey R, et al. : Gamma heavy chain disease in a patient with diabetes and chronic renal insufficiency : diagnostic assessment of the heavy chain fragment. J Clin Lab Anal 22 : 146-150, 2008
5) Bianchi G, Anderson KC, Harris NL, et al. : The heavy chain diseases : clinical and pathologic features. Oncology (Williston Park) 28 : 45-53, 2014
8) Courtois L, Sujobert P : Morphologic features of μ-heavy-chain disease. Blood 130 : 558, 2017
10) Buxbaum J, Gallo G : Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Hematol Oncol Clin North Am 13 : 1235-1248, 1999
P.106 掲載の参考文献
1) McKenna RW, Kyle RA, Kuehl WM, et al. : Plasma cell neoplasms. Swerdlow SH, Campo E, Harris NL, et al. eds. : World Health Organization Classification Tumours of Haematopoietic and lymphoid Tissues, revised 4th Ed., vol 2, IARC Press, pp241-258, 2017
2) Rajkumar SV, Dimopoulos MA, Palumbo A, et al. : International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15 : e538-548, 2014
3) Iwanaga M, Tomonaga M : Prevalence of monoclonal gammopathy of undetermined significance in Asia : a viewpoint from nagasaki atomic bomb survivors. Clin Lymphoma Myeloma Leuk 14 : 18-20, 2014
4) Geipp PR, Kyle RA : Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood 62 : 166-171, 1983
6) 国立がん研究センターがん情報サービス
7) 厚生労働省難治性疾患克服研究事業「免疫性神経疾患に関する調査研究班」
8) Dao LN, Hansen CA, Dispenzieri A, et al. : Bone marrow histopathology in POEMS syndrome : a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood 117 : 6438-6444, 2011
P.114 掲載の参考文献
1) Cook JR, Isaacson PG, Chott A, et al. : Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, 259-262, 2017
2) Isaacson PG, Wright DH : Malignant lymphoma of mucosa-associated lymphoid tissue. Cancer 52 : 1410-1416, 1983
3) Lymphoma study group of Japanese pathologists : The world health organization classification of malignant lymphomas in Japan : Incidence of recently recognized entities, Pathol Int 50 : 696-702, 2000
4) Du MQ : MALT lymphoma : recent advances in aetiology and molecular genetics. J Clin Exp Hematop 47 : 31-42, 2007
6) Thieblemont C, Bertoni F, Copie-Bergman C, et al. : Chronic inflammation and extra-nodal marginalzone lymphomas of MALT-type. Semin Cancer Biol 24 : 33-42, 2014
7) Wotherspoon AC, Doglioni C, Diss TC, et al. : Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342 : 575-577, 1993
8) Neubauer A, Thiede C, Morgner A, et al. : Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89 : 1350-1355, 1997
9) Chen LT, Lin JT, Shyu RY, et al. : Prospective study of Helicobacter pylori eradication therapy in stage I (E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 19 : 4245-4251, 2001
11) Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. : Resistance of t (11 ; 18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357 : 39-40, 2001
12) Treon SP, Xu L, Yang G, et al. : MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 367 : 826-833, 2012
P.120 掲載の参考文献
1) Camacho FI, Algara P, Mollejo M, et al. : Nodal marginal zone lymphoma : a heterogenous tumor : a comprehensive analysis of series of 27 cases. Am J Surg Pathol 27 : 762-771, 2003
2) Swerdlow SH, Campo E, Harris NL, et al. : WHO classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Ed., IARC Press, 2008
3) Taddesse-Heath L, Pittaluga S, Sorbara L, et al. : Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 27 : 522-531, 2003
5) Liu Q, Salaverria I, Pittaluga S, et al. : Follicular lymphoma in children and young adults : a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol 37 : 333-343, 2013
P.123 掲載の参考文献
1) Rappaport H, Winter W, Hicks E : Follicular lymphoma. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9 : 792-821, 1956
2) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas : summary and description of a working formulation for clinical usage. The non-Hodgkin's lymphoma Pathologic Classification Project. Cancer 49 : 2112-2135, 1982
3) Harris NL, Jaffe ES, Stein H, et al. : A revised European-American classification of lymphoid neoplasms : a proposal from the International Lymphoma Study Group. Blood 84 : 1361-1392, 1994
4) Swerdlow SH, Campo E, Harris NL, et al. : WHO classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., IARC Press, 266-277, 2017
5) 中峯寛和, 難波紘二, 大島孝一, 他 : Hodgkinリンパ腫および濾胞性リンパ腫の発生頻度の推移について. 日病理会誌 91 : 346, 2002
6) Lai R, Arber DA, Chang KL, et al. : Frequency of bcl-2 expression in non-Hodgkin lymphoma : a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 11 : 864-869, 1998
9) Lorsbach RB, Shay-Seymore D, Moore J, et al. : Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 99 : 1959-1964, 2002
11) Takata K, Sato Y, Nakamura N, et al. : Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B cell characteristics. Mod Pathol 26 : 22-31, 2013
P.129 掲載の参考文献
1) Jaffe ES, Harris NL, Siebert R, et al. : Paediatric-type follicular lymphoma. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. World Health organization Classification of Tumours, revised 4th Ed., IARC Press, pp278-279, 2017
2) Louissaint A Jr, Ackerman AM, Dias-Santagata D, et al. : Pediatric-type nodal follicular lymphoma : an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood 120 : 2395-2404, 2012
7) Schmidt J, Ramis-Zaldivar JE, Nadeu F, et al. : Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood 130 : 323-327, 2017
P.131 掲載の参考文献
1) Pittaluga S, Harris NL, Siebert R, et al. : Large B-cell lymphoma with IRF4 rearrangement. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. World Health organization Classification of Tumours, revised 4th Ed., IARC Press, pp278-279, 2017
2) Salaverria I, Philipp C, Oschlies I, et al. : Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 118 : 139-147, 2011
P.133 掲載の参考文献
1) Willemze R, Kerl H, Sterry W, et al. : EORTC classification for primary cutaneous lymphomas : a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90 : 354-371, 1997
3) Xie X, Sundram U, Natkunam Y, et al. : Expression of HGAL in primary cutaneous large B-cell lymphomas : evidence for germinal center derivation of primary cutaneous follicular lymphoma. Mod Pathol 21 : 653-659, 2008
5) Kodama K, Massone C, Chott A, et al. : Primary cutaneous large B-cell lymphomas : clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 106 : 2491-2497, 2005
6) Zinzani PL, Quaglino P, Pimpinelli N, et al. : Italian Study Group for Cutaneous Lymphomas. Prognostic factors in primary cutaneous B-cell lymphoma : the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 24 : 1376-1382, 2006
P.136 掲載の参考文献
1) Swedlow SH, et al. : Mantle cell lymphoma. WHO Classification of tumour of haematopoietic and lymphoid tissue, 4th Ed., 229-232, 2008
2) Richard P, Vassallo J, Valmary S, et al. : "In situ-like" mantle cell lymphoma : a report of two cases. J Clin Pathol 59 : 995-996, 2006
3) Campo E, Raffeld M, Jaffe ES : Mantle-cell lymphoma. Semin Haematol 36 : 115-127, 1999
5) Wlodarska I, Dierickx D, Vanhentenrijk V, et al. : Translocations targeting CCND2, CCND3, and MYCN do occur in t (11 ; 14) -negative mantle cell lymphoma. Blood 111 : 5683-5690, 2008
P.141 掲載の参考文献
1) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89 : 3909-3918, 1997
3) Lymphoma Study Group of Japanese Pathologists : The World Health Organization classification of malignant lymphomas in Japan : Incidence of recently recognized entities. Pathol Int 50 : 696-702, 2000
4) Harris NL, Jaffe ES, Stein H, et al. : A revised European-American classification of lymphoid neoplasms : a proposal from the International Lymphoma Study Group. Blood 84 : 1361-1392, 1994
5) Swerdlow SH, Campo E, Harris NL, et al. eds. : WHO classification of tumor, Tumours of haematopoietic and lymphoid tissues, revised 4th Ed., IARC Press, 2017
6) Matolcsy A, Chadburn A, Knowles DM : De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol 147 : 207-216, 1995
P.146 掲載の参考文献
1) The world health organization classification of malignant lymphomas in japan : incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 50 : 696-702, 2000
2) Hartmann S, Doring C, Vucic E, et al. : Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Br J Haematol 169 : 415-422, 2015
3) Lones MA, Cairo MS, Perkins SL : T-cell-rich large B-cell lymphoma in children and adolescents : a clinicopathologic report of six cases from the Children's Cancer Group Study CCG-5961. Cancer 88 : 2378-2386, 2000
P.148 掲載の参考文献
1) Kluin P, Deckert M, Ferry J : Primary diffuse large B-cell lymphoma of the CNS. WHO classification : tumours of haematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow S, Campo E, Harris NL, et al. eds., IARC Press, 300-302, 2017
2) Ferry JA : Diagnosis of Lymphoma in Extranodal sites Other than Skin. Hematopathology, 2nd Ed., Jaffe ES, Arber DA, Campo E, et al. eds., Elsevier, 1133-1138, 2016
3) Brain Tumor Registry of Japan (2005-2008) 14th Edition : Neurologia medico-chirurgica 57 Supplement : 9-102, 2017
4) Imai H, Shimada K, Shimada S, et al. : Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma. Pathol Int 59 : 431-437, 2009
5) Brunn A, Nagel I, Montesinos-Rongen M, et al. : Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYClowBCL2low subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. Acta Neuropathol 126 : 603-605, 2013
6) Cady FM, O'Neill BP, Law ME, et al. : Del (6) (q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol 26 : 4814-4819, 2008
7) Riemersma SA, Oudejans JJ, Vonk MJ, et al. : High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis. J Pathol 206 : 328-336, 2005
9) Bromberg JEC, Siemers MD, Taphoorn MJ : Is a "vanishing tumor" always a lymphoma? Neurology 59 : 762-764, 2002
P.150 掲載の参考文献
1) Willemze R, Kerl H, Sterry W, et al. : EORTC classification for primary cutaneous lymphomas : a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90 : 354-371, 1997
3) Kodama K, Massone C, Chott A, et al. : Primary cutaneous large B-cell lymphomas : clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 106 : 2491-2497, 2005
4) Zinzani PL, Quaglino P, Pimpinelli N, et al. : Prognostic factors in primary cutaneous B-cell lymphoma : the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 24 : 1376-1382, 2006
6) Koens L, Vermeer MH, Willemze R, et al. : IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma. Am J Surg Pathol 34 : 1043-1048, 2010
P.152 掲載の参考文献
1) Oyama T, Ichimura K, Suzuki R, et al. : Senile EBV+ B-cell lymphoproliferative disorders : a clinicopathologic study of 22 patients. Am J Surg Pathol 27 : 16-26, 2003
2) Oyama T, Yamamoto K, Asano N, et al. : Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group : a study of 96 patients. Clin Cancer Res 13 : 5124-5132, 2007
3) Nakamura S, Jaffe ES, Swerdlow SH : EBV positive diffuse large B-cell lymphoma, NOS. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swedlow SH, Campo E, Harris NL, et al. eds., IARC Press, pp304-306, 2017
4) Nicolae A, Pittaluga S, Abdullah S, et al. : EBV-positive large B-cell lymphomas in young patients : a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 126 : 863-872, 2015
5) Asano N, Yamamoto K, Tamaru JI, et al. : Age-related EBV-associated B-cell lymphoproliferative disorders : comparison with EBV-positive classical Hodgkin lymphoma in elderly patients. Blood 113 : 2629-2636, 2009
P.155 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL, et al. : WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th Ed., International Agency for Research on Cancer (IARC), 307-308, 2017
3) Dojcinov SD, Venkataraman G, Pittaluga S, et al. : Age-related EBV-associated lymphoproliferative disorders in the Western polulation: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117 : 4726-4735, 2011
5) Bunn B, van Heerden W : EBV-positive mucocutaneous ulcer of the oral cavity associate with HIV/AIDS. Oral Surg Oral Med Oral Pathol Oral Radiol 120 : 725-732, 2015
P.157 掲載の参考文献
1) Iuchi K, Ichimiya A, Akashi A, et al. : Non-Hodgikin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 60 : 1771-1775, 1987
3) Hongo T, Kurooka M, Taniguchi E, et al. : Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma. Cancer Res 58 : 1105-1107, 1998
4) Yamato H, Ohshima K, Suzumiya J, et al. : Evidence for local immunosuppresion and demonstration of c-myc amplification in pyothorax-associated lymphoma. Histopathol 39 : 163-171, 2001
5) Nishiu M, Tomita Y, Nakatsuka S, et al. : Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation. Cancer Sci 95 : 828-834, 2004
6) Boyer DF, McKelvie PA, de Leval L, et al. : Fibrin-associated EBV-positive Large B-cell lymphoma : An indolent neoplasm with feature distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol 41 : 299-312, 2017
7) Kameda K, Shono T, Takagishi S, et al. : Epstein-Barr virus-positive diffuse large B-cell primary central nervous system lymphoma associated with organizing chronic subdural hematoma : a case report and review of the literature. Pathol Int 65 : 138-143, 2015
P.160 掲載の参考文献
1) Liebow AA, Carrington CR, Friedman PJ : Lymphomatoid granulomatosis. Hum Pathol 3 : 457-558, 1972
2) Katzenstein AL, Doxader E, Narendra S : Lymphomatoid granulomatosis : insights gained over 4 decades. Am J Surg Pathol 12 : e35-48, 2010
3) Swerdlow SH, Campo E, Harris NL, et al. : World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., IARC Press, 312-314, 2017
4) Katzenstein AL, Carrington CB, Liebow AA : Lymphomatoid granulomatosis : a clinicopathologic study of 152 cases. Cancer 43 : 360-373, 1979
5) Koss MN, Hochholzer L, Langloss JM, et al. : Lymphomatoid granulomatosis : a clinicopathologic study of 42 patients. Pathology 18 : 283-288, 1986
6) Guinee DG Jr, Jaffe E, Kingma D, et al. : Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 18 : 753-764, 1994
P.164 掲載の参考文献
1) Miller JB, Variakojis D, Bitran JD, et al. : Diffuse histiocytic lymphoma with sclerosis : a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer 47 : 748-756, 1981
2) Moller P, Lammler B, Eberlein-Gonska M, et al. : Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch A Pathol Anat Histopathol 409 : 79-92, 1986
3) Perrone T, Frizzera G, Rosai J : Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol 10 : 176-191, 1986
4) Barth TF, Leithauser F, Joos S, et al. : Mediastina (l thymic) large B-cell lymphoma : where do we stand? Lancet Oncol 3 : 229-234, 2002
5) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89 : 3909-3918, 1997
6) Cazals-Hatem D, Lepage E, Brice P, et al. : Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d 'Etude des Lymphomes de l' Adulte") study. Am J Surg Pathol 20 : 877-888, 1996
7) The world health organization classification of malignant lymphomas in japan : incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 50 : 696-702, 2000
8) Pileri SA, Gaidano G, Zinzani PL, et al. : Primary mediastinal B-cell lymphoma : high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol 162 : 243-253, 2003
9) Higgins JP, Warnke RA : CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 112 : 241-247, 1999
10) Calaminici M, Piper K, Lee AM, et al. : CD23 expression in mediastinal large B-cell lymphomas. His topathology 45 : 619-624, 2004
11) de Leval L, Ferry JA, Falini B, et al. : Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma : evidence for derivation from germinal center B cells? Am J Surg Pathol 25 : 1277-1282, 2001
12) Gentry M, Bodo J, Durkin L, et al. : Performance of a Commercially Available MAL Antibody in the Diagnosis of Primary Mediastinal Large B-Cell Lymphoma. Am J Surg Pathol 41 : 189-194, 2017
13) Kanavaros P, Gaulard P, Charlotte F, et al. : Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. Am J Pathol 146 : 735-741, 1995
14) Nakagawa A, Nakamura S, Koshikawa T, et al. : Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese. Acta Pathol Jpn 43 : 44-54, 1993
16) Bentz M, Barth TF, Bruderlein S, et al. : Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL) : comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 30 : 393-401, 2001
18) Joos S, Otano-Joos MI, Ziegler S, et al. : Primary mediastina (l thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87 : 1571-1578, 1996
P.168 掲載の参考文献
1) Ferreri AJ, Dognini GP, Campo E, et al. : Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 92 : 486-492, 2007
2) Murase T, Yamaguchi M, Suzuki R, et al. : Intravascular large B-cell lymphoma (IVLBCL) : a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109 : 478-485, 2007
4) Ponzoni M, Ferreri AJ, Campo E, et al. : Definition, diagnosis, and management of intravascular large B-cell lymphoma : proposals and perspectives from an international consensus meeting. J Clin Oncol 25 : 3168-3173, 2007
5) Shimada K, Kinoshita T, Naoe T, et al. : Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 10 : 895-902, 2009
6) Tomita A, Shimada K, Yoshida K, et al. : Detection of Recurrent Genetic Mutations in Intravascular Large B-Cell Lymphoma By Comprehensive Genetic Analyses Using Peripheral Blood Circulating Cell-Free DNA. Blood 130 : 1452, 2017
7) Ferreri AJ, Campo E, Seymour JF, et al. : Intravascular lymphoma : clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 127 : 173-183, 2004
8) Matsue K, Asada N, Odawara J, et al. : Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma. Ann Hematol 90 : 417-421, 2011
9) Ferreri AJ, Dognini GP, Bairey O, et al. : The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma. Br J Haematol 143 : 253-257, 2008
10) Ferreri AJ, Dognini GP, Govi S, et al. : Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma? J Clin Oncol 26 : 5134-5136 ; author reply 5136-5137, 2008
11) Shimada K, Matsue K, Yamamoto K, et al. : Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26 : 3189-3195, 2008
12) Shimada K, Murase T, Matsue K, et al. : Central nervous system involvement in intravascular large B-cell lymphoma : a retrospective analysis of 109 patients. Cancer Sci 101 : 1480-1486, 2010
13) Matsue K, Hayama BY, Iwama K, et al. : High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer 117 : 4512-4521, 2011
P.172 掲載の参考文献
1) Del sol G, Lamant L, Mariame B, et al. : A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2 ; 5 translocation. Blood 89 : 1483-1490, 1997
2) Jaffe ES, Harris NL, Stein H, et al. eds. : WHO Classification Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, 2000
3) Gascoyne R, Lamant L, Martin-Subero JI, et al. : ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements : report of six cases. Blood 102 : 2568-2573, 2003
4) Delsol G, Campo E, Gascoyne R : ALK-positive large B-cell lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, 254-255, 2008
5) Campo E, Gascoyne R : ALK-positive large B-cell lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, 319-320, 2017
6) Pan Z, Hu S, Li M, et al. : ALK-positive Large B-cell Lymphoma : A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature. Am J Surg Pathol 41 : 25-38, 2017
7) Jiang XN, Yu BH, Wang WG, et al. : Anaplastic lymphoma kinase-positive large B-cell lymphoma : Clinico-pathological study of 17 cases with review of literature. PLoS One 12 : e0178416, 2017
8) Hashimoto T, Fujimoto M, Nishikori M, et al. : Plasmacytic ALK-positive large B-cell lymphoma : a potential mimic of extramedullary plasmacytoma. Pathol Int 64 : 292-294, 2014
9) Sakamoto K, Nakasone H, Togashi Y, et al. : ALK-positive large B-cell lymphoma : identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern. Int J Hematol 103 : 399-408, 2016
11) Valera A, Colomo L, Martinez A, et al. : ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol 26 : 1329-1337, 2013
13) Shi M, Miron PM, Hutchinson L, et al. : Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements. Hum Pathol 42 : 1562-1567, 2011
P.176 掲載の参考文献
1) Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. : Plasmablastic lymphomas of the oral cavity : a new entity associated with the human immunodeficiency virus infection. Blood 89 : 1413-1420, 1997
2) Carbone A : AIDS-related non-Hodgkin's lymphomas : from pathology and molecular pathogenesis to treatment. Hum Pathol 33 : 392-404, 2002
P.178 掲載の参考文献
1) Knowles DM, Inghirami G, Ubriaco A, et al. : Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 73 : 792-799, 1989
3) Carbone A, Gloghini A : PEL and HHV8-unrelated effusion lymphomas : classification and diagnosis. Cancer Cytopathol 114 : 225-227, 2008
5) 大田泰徳, 比島恒和, 望月眞, 他 : エイズ関連リンパ腫の病理診断. 病理と臨 30 : 195-203, 2012
7) Ascoli V, Scalzo CC, Danese C, et al. : Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men. Eur Respir J 14 : 1231-1234, 1999
8) 片野晴隆 : ヒトヘルペスウイルス 8 (HHV-8) の感染病理学的研究. ウイルス 53 : 95-102, 2003
9) Coupland SE, Charlotte F, Mansour G, et al. : HHV-8-associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man. Am J Surg Pathol 29 : 647-652, 2005
11) Chadburn A, Hyjek E, Mathew S, et al. : KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 28 : 1401-1416, 2004
P.183 掲載の参考文献
1) Said J, Isaacson PG, Campo E, et al. : HHV8-associated lymphoproliferative disorders. WHO Classification of Tumours of Haematopoetic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL, et al. eds., International Agency for Research on Cancer (IARC) Press, 325-329, 2017
2) Suda T, Katano H, Delsol G, et al. : HHV8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease. Pathol Int 51 : 671-679, 2001
3) Dupin N, Diss TL, Kellam P, et al. : HHV8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV8-positive plasmablastic lymphoma. Blood 95 : 1406-1412, 2000
5) Oksenhendler E, Boulanger E, Galicier L, et al. : High incidence of Kaposi sarcoma-associated herpesvirus -related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99 : 2331-2336, 2002
P.188 掲載の参考文献
1) Mol yneux EM, Rochford R, Griffin B, et al. : Burkitt's lymphoma. Lancet 379 : 1234-1244, 2012
2) Spender LC, Inman GJ : Developments in Burkitt's lymphoma : novel cooperations in oncogenic MYC signaling. Cancer Manag Res 6 : 27-38, 2014
6) Nakamura N, Nakamine H, Tamaru J, et al. : The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement. Mod Pathol 15 : 771-776, 2002
10) Momose S, Weisbach S, Pischimarov J, et al. : The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum. Leukemia 29 : 1789-1791, 2015
P.193 掲載の参考文献
P.195 掲載の参考文献
1) Traverse-Glehen A, Pittaluga S, Gaulard P, et al. : Mediastinal gray zone lymphoma : the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymhoma. Am J Surg Pathol 29 : 1411-1421, 2005
2) Jaffe ES, Stein H, Swerdlow SH, et al. : B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swedlow SH, Campo E, Harris NL, et al. eds., IARC Press, pp342-344, 2017
P.197 掲載の参考文献
1) Matutes E, Catovsky D, Muller-Hermalink HK : T-cell prolymphocytic leukemia. WHO Classfication of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swerdlow S, Campo E, Harris NL, et al. eds., IARC Press, P346-347, 2017
2) Lymphoma Study Group of Japanese Pathologists : The world health organization classification of malignant lymphomas in Japan : incidence of recently recognized entities. Pathol Int 50 : 696-702, 2000
3) Matutes E, Brito-Babapulle V, Swansbury J, et al. : Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78 : 3269-3274, 1991
P.199 掲載の参考文献
1) Chan WC, Foucar K, Morice WG, et al. : T-cell large grade lymphocytic leukaemia. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, P348-350, 2017
2) Oshimi K, Yamada O, Kaneko T, et al. : Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 7 : 782-788, 1993
4) Lymphoma Study Group of Japanese Pathologists : The world health organization classification of malignant lymphomas in Japan : incidence of recently recognized entities. Pathol Int 50 : 696-702, 2000
5) Morice WG, Kurtin PJ, Tefferi A, et al. : Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA1, and granzyme B. Blood 99 : 268-274, 2002
6) Kreutzman A, Juvonen V, Kairisto V, et al. : Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy. Blood 116 : 772-782, 2010
P.201 掲載の参考文献
1) Oshimi K, Yamada O, Kaneko T, et al. : Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 7 : 782-788, 1993
3) Neben MA, Morice WG, Tefferi A : Clinical features in T-cell vs. natural killer-cell variants of large granular lymphocyte leukemia. Eur J Haematol 71 : 263-265, 2003
4) Lima M, Almeida J, Montero AG, et al. : Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 165 : 1117-1127, 2004
5) Bareau B, Rey J, Hamidou M, et al. : Analysis of a French cohort of patients with large granular lymphocyte leukemia : a report on 229 cases. Haematologica 95 : 1534-1541, 2009
9) Ohshima K, Kimura H, Yoshino T, et al. : Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults : overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58 : 209-217, 2008
10) Gattazzo C, Teramo A, Passeri F, et al. : Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. Haematologica 99 : 1826-1833, 2014
P.203 掲載の参考文献
1) Chan JKC, Jaffe ES, Ko Y-H : Aggressive NK-cell leukaemia. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NK, et al. eds., International Agency for Research on Cancer (IARC) Press, P353-354, 2017
4) Lymphoma Study Group of Japanese Pathologists : The world health organization classification of malignant lymphomas in Japan : incidence of recently recognized entities. Pathol Int 50 : 696-702, 2000
7) Ohshima K, Haraoka S, Ishihara S, et al. : Analysis of chromosome 6q deletion in EBV-associated NK cell leukaemia/lymphoma. Leuk Lymphoma 43 : 293-300, 2002
10) Suzuki R, Suzumiya J, Oshimi K : Differences between nasal and extranasal NK/T-cell lymphoma. Blood 113 : 6260-6261 ; author reply 6261-6262, 2009
P.205 掲載の参考文献
2) Quintanilla-Martinez L, Ko YH, Kimura H, et al. : EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, p355-362, 2017
3) Quintanilla-Martinez L, Kumar S, Fend F, et al. : Fulminant EBV (+) T-cell lymphoproliferative disorder following acute/chronic EBV infection : a distinct clinicopathologic syndrome. Blood 96 : 443-451, 2000
4) Ohshima K, Kimura H, Yoshino T, et al. : Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults : overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58 : 209-217, 2008
6) 日本小児感染症学会監 : 慢性活動性EBウイルス感染症とその類縁疾患の診療ガイドライン 2016, 診断と治療社, 2016
7) Ohshima K, Suzumiya J, Ohga S, et al. : Integrated Epstein-Barr virus (EBV) and chromosomal abnormality in chronic active EBV infection. Int J Cancer 71 : 943-947, 1997
9) Kimura H, Ito Y, Kawabe S, et al. : EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts : prospective analysis of 108 cases. Blood 119 : 673-686, 2012
P.211 掲載の参考文献
1) Takatsuki K : Overview of adult T-cell leukemia/lymphoma. Jpn Soc Res 25 : 97-103, 1985
2) Tajima K, Hinuma Y : Epidemiology of HTLV-I/II in Japan and the world. Gann Mono Can Res 39 : 129-149, 1992
3) Ohshima K, Suzumiya J, Sato M, et al. : survival of patients with HTLV-I-associated lymph node lesions. J Pathology 189 : 539-545, 1999
4) 城野昌義 : 皮膚科からみた成人T細胞白血病・リンパ腫. 成人T細胞白血病・リンパ腫 (血液科学シリーズ 6), 高月清編, 西村書店, p55-84, 1992
7) Ishida T, Utsunomiya A, Iida S, et al. : Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma : Its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9 (10 Pt 1) : 3625-3634, 2003
8) Watanabe T, Yamaguchi K, Takatsuki K, et al. : Constitutive expression of parathyroid hormone-related protein (PTHrP) gene in HTLV-I carriers and adult T cell leukemia patients which can be trans-activated by HTLV-I Tax gene. J Exp Med 172 : 759-765, 1990
9) Shimoyama M, members of The Lymphoma Study Group (1984-87) : Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia/lymphoma. Br J Haematol 79 : 428-437, 1991
10) Takatsuki K, Yamaguchi K, Watanabe T : Adult T-cell leukemia and HTLV-I related diseases. Gann Mono Can Res 39 : 1-15, 1992
P.215 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL, et al. eds. : WHO classification of tumor, Tumours of haematopoietic and lymphoid tissues, revised 4th Ed., IARC Press, 2017
2) Lymphoma Study Group of Japanese Pathologists. The world health organization classification of malignant lymphomas in japan : incidence of recently recognized entities. Pathol Int 50 : 696-702, 2000
4) Arber DA, Weiss LM, Albujar PF, et al. : Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17 : 392-399, 1993
5) Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al. : Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 11 : 754-761, 1998
6) Tien HF, Su IJ, Tang JL, et al. : Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. Br J Haematol 97 : 621-625, 1997
8) International T-cell lymphoma project. International peripheral T-cell and natural killer/T-cell lymphoma study : Pathology findings and clinical findings. JCO 26 : 4124-4129, 2008
P.219 掲載の参考文献
1) Isaacson P, Wright DH : Intestinal lymphoma associated with malabsorption. Lancet 1 : 67-70, 1978
2) O'Farrelly C, Feighery C, O'brian DS, et al. : Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J 293 : 908-910, 1986
3) Isaacson PG, Chott A, Ott G, et al. : Enteropathy-associated T-cell lymphoma. Swerdlow SH, Campo E, Harris NL, et al. eds. : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Ed., IARC Press, pp289-291, 2008
8) Lymphoma Study Group of Japanese Pathologists : The World Health Organization classification of malignant lymphomas in Japan : Incidence of recently recognized entities. Pathol Int 50 : 696-702, 2000
10) Chan JKC, Chan ACL, Cheuk W, et al. : Type II Enteropathy-associated T-cell lymphoma : A distinct aggressive lymphoma with frequentγδ T-cell receptor expression. Am J Surg Pathol 35 : 1557-1569, 2011
P.224 掲載の参考文献
1) Cooke CB, Krenacs L, Stetler-Stevenson M, et al. : Hepatosplenic T-cell lymphoma : a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88 : 4265-4274, 1996
4) Rosh JR, Gross T, Mamula P, et al. : Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease : a cautionary tale? Inflamm Bowel Dis 13 : 1024-1030, 2007
6) Sallah S, Smith SV, Long LC, et al. : Gamma/delta T-cell hepatosplenic lymphoma : review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia. Ann Hematol 74 : 139-142, 1997
7) Lai R, Larratt LM, Etches W, et al. : Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presetting with hemolytic anemia and thrombocytopenia. Am J Surg Pathol 24 : 459-463, 2000
8) Nicolae A, Xi L, Pittaluga S, et al. : Frequent STAT5B mutations in γδhepatosplenic T-cell lymphomas. Leukemia 28 : 2244-2248, 2014
9) Wlodarska I, Martin-Garcia N, Achten R, et al. : Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma : isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 33 : 243-251, 2002
10) Ohshima K, Haraoka S, Harada N, et al. : Hepatosplenic gamma/delta lymphoma : relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology 36 : 127-135, 2000
11) Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. : Nonhepatosplenic gammadelta T-cell lymphoma : a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 91 : 1723-1731, 1998
P.228 掲載の参考文献
1) Wang CY, Su WP, Kurtin PJ : Subcutaneous panniculitic T-cell lymphoma. Int J Dermatol 35 : 1-8, 1996
2) Kurmar S, Krenacs L, Medeiros J, et al. : Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol 29 : 397-403, 1998
3) Gonzalez CL, Medeiros LJ, Braziel RM, et al. : T-cell lymphoma involving subcutaneous tissues. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 15 : 17-27, 1991
5) Salhany KE, Macon WR, Choi JK, et al. : Subcutaneous panniculitis-like T-cell lymphoma : clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 22 : 881-893, 1998
6) Swerdlow SH, Campo E, Harris NL, et al. eds. : WHO classification of tumor, Tumours of haematopoietic and lymphoid tissues, 4th Ed., IARC Press, 2008
P.232 掲載の参考文献
1) Kim YH, Hoppe RT : Mycosis fungoides and the Sezary syndrome. Semin Oncol 26 : 276-289, 1999
3) Colby TV, Burke JS, Hoppe RT : Lymph node biopsy in mycosis fungoides. Cancer 47 : 351-359, 1981
4) Warnke RA, Weiss LM, Chan JKC, et al. : Tumors of the lymph nodes and spleen. Atlas of tumor pathology, 3rd Ed., AFIP, 245-258, 1994
5) Ralfkiaer E : Immunohistological markers for the diagnosis of cutaneous lymphomas. Semin Diagn Pathol 8 : 62-72, 1991
7) Scarisbrick JJ, Woolford AJ, Russell-Jones R, et al. : Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95 : 2937-2942, 2000
8) Willemze R, Kerl H, Sterry W, et al. : EORTO classification for primary cutaneous lymphomas : a proposal from the European Organization for Research and Treatment of Cancer. Blood 90 : 354-371, 1997
9) van Doorn R, Van Haselen CW, Voorst Vader PC, et al. : Mycosis fungoides : disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 136 : 504-510, 2000
10) Diamandidou E, Colome M, Fayad L, et al. : Prognostic factor analysis in mycosis fungoides/Sezary syndrome. J Am Acad Dermatol 40 (6 Pt 1) : 914-924, 1999
11) Cerroni L, Rieger E, Hodl S, et al. : Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol 16 : 543-552, 1992
P.237 掲載の参考文献
P.239 掲載の参考文献
1) Willemze R, Kerl H, Sterry W, et al. : EORTC classification for primary cutaneous lymphomas : a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90 : 354-371, 1997
3) Willemze R, Paulli M, Kadin ME : Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th Ed., IARC Press, 392-396, 2017
4) Cerroni L : Primary cutaneous CD30+ lymphoproliferative disorders. Skin lymphoma, the illustrated guide, 4th Ed., Wiley-Blackwell, 85-119, 2014
5) 濱田利久, 岩月啓氏 : 皮膚リンパ腫 全国症例数調査の結果 2016. 第33回日本皮膚悪性腫瘍学会学術大会, 2017
7) Benner MF, Janse PM, Meijer CJ, et al. : Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatrol 161 : 121-127, 2009
P.242 掲載の参考文献
P.246 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL, et al. eds. : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th Ed., IARC Press, 2017
4) The world health organization classification of malignant lymphomas in japan : incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 50 : 696-702, 2000
5) Lennert K, Feller A : Histopathology of Non-Hodgkin's Lymphomas, 2nd Ed., Springer-Verlag, 1992
6) Kagami Y, Suzuki R, Taji H, et al. : Nodal cytotoxic lymphoma spectrum : a clinicopathologic study of 66 patients. Am J Surg Pathol 23 : 1184-1200, 1999
7) Yamashita Y, Nakamura S, Kagami Y, et al. : Lennert's lymphoma : a variant of cytotoxic T-cell lymphoma? Am J Surg Pathol 24 : 1627-1633, 2000
8) Went P, Agostinelli C, Gallamini A, et al. : Marker expression in peripheral T-cell lymphoma : a proposed clinical-pathologic prognostic score. J Clin Oncol 24 : 2472-2479, 2006
9) Warnke RA, Jones D, Hsi ED : Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics. Am J Clin Pathol 127 : 511-527, 2007
11) Zettl A, Rudiger T, Konrad MA, et al. : Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 164 : 1837-1848, 2004
P.251 掲載の参考文献
P.258 掲載の参考文献
1) Falini B, Stein H, Lamant-Rochaix L, et al. : Anaplastic large cell lymphoma, ALK-positive. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. World Health Organization Classification of Tumours, revised 4th Ed., IARC Press, pp413-418, 2017
2) Stein H, Mason DY, Gerdes J, et al. : The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue : evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 : 848-858, 1985
3) Kadin ME, Sako D, Berliner N, et al. : Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 68 : 1042-1049, 1986
4) Morris SW, Kirstein MN, Valentine MB, et al. : Fusion of a kinase gene, ALK, to nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 : 1281-1284, 1994
5) Shiota M, Fujimoto J, Semba T, et al. : Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9 : 1567-1574, 1994
6) Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. : ALK-positive lymphoma : a single disease with a broad spectrum of morphology. Blood 91 : 2076-2084, 1998
7) Foss HD, Anagnostopoulos I, Araujo I, et al. : Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 88 : 4005-4011, 1996
9) Lamant L, McCarthy K, d'Amore ESG, et al. : Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large cell lymphoma (ALCL) : Results of the ALCL99 study. J Clin Oncol 29 : 4669-4676, 2011
P.262 掲載の参考文献
1) Feldman AL, Jaffe ES, Harris NL, et al. : Anaplastic large cell lymphoma, ALK-negative. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. World Health Organization Classification of Tumours, revised 4th Ed., IARC Press, pp418-421, 2017
4) Savage KJ, Harris NL, Vose JM, et al. : ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified : report from the International Peripheral T-Cell Lymphoma Project. Blood 111 : 5496-5504, 2008
5) Boi M, Rinaldi A, Kwee I, et al. : PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood 122 : 2683-2693, 2013
P.265 掲載の参考文献
P.268 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL, et al. eds. : WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th Ed., IARC Press, 2017
2) Stein H, Hansmann ML, Lennert K, et al. : Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 86 : 292-297, 1986
3) Tamaru J, Mikata A, Azuma K, et al. : Reciprocal/dichotomic expression of vimentin and B cell differentiation antigens in Reed-Sternberg's cells. Virchows Arch A Pathol Anat Histopathol 416 : 213-220, 1990
4) Anagnostopoulos I, Hansmann ML, Franssila K, et al. : European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease : histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96 : 1889-1899, 2000
6) Poppema S : The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol 135 : 351-357, 1989
11) Atayar C, Kok K, Kluiver J, et al. : BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV. Hum Pathol 37 : 675-683, 2006
12) Renne C, Martin-Subero JI, Hansmann ML, et al. : Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition. J Mol Diagn 7 : 352-356, 2005
13) Wlodarska I, Stul M, De Wolf-Peeters C, et al. : Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma. Haematologica 89 : 965-972, 2004
14) Chittal SM, Alard C, Rossi JF, et al. : Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. Am J Surg Pathol 14 : 1024-1035, 1990
15) Hansmann ML, Stein H, Fellbaum C, et al. : Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 20 : 1169-1175, 1989
16) Miettinen M, Franssila KO, Saxen E : Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer 51 : 2293-2300, 1983
17) Al-Mansour M, Conners JM, Gascoyne RD, et al. : Transformation to aggressive lymphoma in modular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol 28 : 793-799, 2010
18) Greiner TC, Gascoyne RD, Anderson ME, et al. : Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma : analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood 88 : 657-666, 1996
19) Wickert RS, Weisenburger DD, Tierens A, et al. : Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 86 : 2312-2320, 1995
20) Shimodaira S, Hidaka E, Katsuyama T : Clonal identity of nodular lymphocyte-predominant Hodgkin's disease and T-cell-rich B-cell lymphoma. New Engl J Med 343 : 1124-1125, 2000
21) Prakash S, Fountaine T, Raffeld M, et al. : IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 30 : 585-592, 2006
P.273 掲載の参考文献
1) Swerdl ow SH, Campo E, Harris HL, et al. eds. : World health organization classification of tumours of haematopoietic and lymphoid tissues, revised 4th Ed., IARC Press, 2017
2) Hodgkin T : On some Morbid Appearances of the Absorbent Glands and Spleen. Med Chir Trans 17 : 68-114, 1832
3) Wilks S : Cases of enlargement of the lymphatic glands and spleen (or Hodgkin's disease), with remarks. Guy's Hosp Rep 11 : 56-67, 1865
4) Sternberg C : Uber eine eigenartige unter dem Bilde der Pseudoleukamie verlaufende Tuberkulose des lymphatischen Apparates. Zeitschr Heilk 19 : 21-90, 1898
5) Reed DM : On the pathological changes in Hodgkin's disease with especial reference to its relation to tuberculosis. Johns Hopkins Hosp Rep 10 : 133-196, 1902
6) Stein H, Mason DY, Gerdes J, et al. : CD30 (+) anaplastic large cell lymphoma : a review of its histopathologic, genetic, and clinical features. Blood 66 : 848-858, 1985
7) Tamaru J, Mikata A, Azuma K, et al. : Reciprocal/dichotomic expression of vimentin and B cell differentiation antigens in Reed-Sternberg's cells. Virchows Arch A Pathol Anat Histopathol 416 : 213-220, 1990
8) Cunningham WF : The status of diphtheroids with special reference to Hodgkin's disease. Am J Med Sci 153 : 406-412, 1917
9) Yates JL, Bunting CH : The rational treatment of Hodgkin's disease. JAMA 64 : 1953-1961, 1915
10) Tamaru J, Hummel M, Zemlin M, et al. : Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood 84 : 708-715, 1994
11) Kuppers R, Rajewsky K, Zhao M, et al. : Hodgkin disease : Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cell at various stages of development. Proc Natl Acad Aci U.S.A. 91 : 10962-10966, 1994
12) Kanzler H, Kuppers R, Hansmann ML, et al. : Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184 : 1495-1505, 1996
13) 田丸淳一 : わが国のホジキンリンパ腫の特徴と他疾患との鑑別ポイント. 血液内科 64 : 227-232, 2012
14) Schwab U, Stein H, Gerdes J, et al. : Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299 : 65-67, 1982
15) Stein H, Uchanska-Ziegler B, Gerdes J, et al. : Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer 29 : 283-290, 1982
16) Schwering I, Brauninger A, Klein U, et al. : Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101 : 1505-1512, 2003
17) Seitz V, Hummel M, Marafioti T, et al. : Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95 : 3020-3024, 2000
18) Marafioti T, Hummel M, Foss HD, et al. : Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95 : 1443-1450, 2000
19) Stein H, Marafioti T, Foss HD, et al. : Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97 : 496-501, 2001
23) Ushmorov A, Leithauser F, Sakk O, et al. : Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 107 : 2493-2500, 2006
26) Aldinucci D, Gloghini A, Pinto A, et al. : The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol 221 : 248-263, 2010
30) Kato M, Sanada M, Kato I, et al. : Frequent inactivation of A20 in B-cell lymphomas. Nature 459 : 712-716, 2009
32) Joos S, Kupper M, Ohl S, et al. : Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 60 : 549-552, 2000
34) Raab-Traub N, Flynn K : The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47 : 883-889, 1986
35) 田丸淳一 : EBウイルス (EBV) とリンパ網内系疾患 ホジキンリンパ腫. 血液・腫瘍科 56 : 299-305, 2008
37) Tanijiri T, Shimizu T, Uehira K, et al. : Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+ CD35+ Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells. J Leukoc Biol 82 : 576-584, 2007
38) Kelley TW, Pohlman B, Elson P, et al. : The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J Clin Pathol 128 : 958-965, 2007
39) Steidl C, Lee T, Shah SP, et al. : Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362 : 875-885, 2010
40) Green MR, Monti S, Rodig SJ, et al. : Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116 : 3268-3277, 2010
42) Ansell SM, Lesokhin AM, Borrello I, et al. : PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med 372 : 311-319, 2015
43) Carbone PP, Kaplan HS, Musshoff K, et al. : Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31 : 1860-1861, 1971
45) Hasenclever D, Diehl V : A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339 : 1506-1514, 1998
47) Oyama T, Ichimura K, Suzuki R, et al. : Senile EBV+ B-cell lymphoproliferative disorders : a clinicopathologic study of 22 patients. Am J Surg Pathol 27 : 16-26, 2003
49) Colby TV, Hoppe RT, Warnke RA : Hodgkin's disease : a clinicopathologic study of 659 cases. Cancer 49 : 1848-1858, 1982
50) Shimabukuro-Vornhagen A, Haverkamp H, Engert A, et al. : Lymphocyte-rich classical Hodgkin's lymphoma : clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials. J Clin Oncol 23 : 5739-5745, 2005
51) MacLennan KA, Bennett MH, Vaughan Hudson B, et al. : Diagnosis and grading of nodular sclerosing Hodgkin's disease : a study of 2190 patients. Int Rev Exp Pathol 33 : 27-51, 1992
53) Anagnostopoulos I, Hansmann ML, Franssila K, et al. : European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease : histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96 : 1889-1899, 2000
55) Allemani C, Sant M, DeAngelis R, et al. : Hodgkin disease survival in Europe and the U.S. : prognostic significance of morphologic groups. Cancer 107 : 352-360, 2006
57) Herndier BG, Sanchez HC, Chang KL, et al. : High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. 142 : 1073-1079, 1993
P.283 掲載の参考文献
1) Van Krieken JH, Onciu M, Elenitoba-Johnson KSJ, et al. : Lymphoproliferative diseases associated with primary immune disorders. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. World Health organization Classification of Tumours, revised 4th Ed., IARC Press, pp444-448, 2017
6) Elenitobe-Johnson KS, Jaffe ES : Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 14 : 35-48, 1997
9) Mieraw GW, Greffe BS, Weeks DA, et al. : Primary leiomyosarcoma of brain in adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol 21 : 301-305, 1997
10) Straus SE, Jaffe ES, Puck JM, et al. : The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98 : 194-200, 2001
P.286 掲載の参考文献
P.290 掲載の参考文献
1) Swerdlow SH, Webber SA, Chadbrn A, et al. : Post-transplant lymphoproliferative disorders. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissue, 4th Ed., Swerdlow, SH, Campo E, Harris NL. et al. eds., IARC Press, 343-349, 2008
2) Penn I, Hammond W, Brettschneider L, et al. : Malignant lymphomas in transplantation patients. Transplant Proc 1 : 106-112, 1969
3) Swerdlow SH, Craig FE : Iatrogenic Immunodeficiency Associated Lymphoproliferative disorders. Hematopathology, Jaffe ES, Vardiman J, Campo E, et al. eds., Saunders, 854-866, 2010
4) Niedobitek G, Herbst H, Young LS, et al. : Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79 : 2520-2526, 1992
7) Dotti G, Fiocchi R, Motta T, et al. : Primary effusion lymphoma after heart transplantation : a new entity associated with human herpesvirus-8. Leukemia 13 : 664-670, 1999
10) Wu TT, Swerdlow SH, Locker J, et al. : Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol 27 : 157-164, 1996
P.296 掲載の参考文献
P.300 掲載の参考文献
1) Ralfkiaer E, Delsol G, O'Connor NT, et al. : Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol 160 : 9-17, 1990
7) Copie-Bergman C, Wotherspoon AC, Norton AJ, et al. : True histiocytic lymphoma : a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol 22 : 1386-1392, 1998
8) Pileri SA, Grogan TM, Harris NL, et al. : Tumours of histiocytes and accessory dendritic cells : an immunohistochemical approach to classification from the international lymphoma study group based on 61 cases. Histopathology 41 : 1-29, 2002
9) Hornick JL, Jaffe ES, Fletcher CD : Extranodal histiocytic sarcoma : clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 28 : 1133-1144, 2004
11) Takahashi E, Nakamura S : Histiocytic sarcoma : An updated literature review based on the 2008 WHO classification. J Clin Exp Hematopathol 53 : 1-8, 2013
P.304 掲載の参考文献
2) Pileri SA, Grogan TM, Harris NL, et al. : Tumours of histiocytes and accessory dendritic cells : an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41 : 1-29, 2002
5) Yousem SA, Colby TV, Chen YY, et al. : Pulmonary Langerhans' cell histiocytosis : molecular analysis of clonality. Am J Surg Pathol 25 : 630-636, 2001
8) Roden AC, Hu X, Kip S, et al. : BRAF V600E expression in Langerhans cell histiocytosis : clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 38 : 548-551, 2014
P.308 掲載の参考文献
1) Weiss LM, Chan JKC, Fletcher CDM : Indeterminate dendritic cell tumor. WHO classification of tumors of hematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, p474, 2017
3) O'Malley DP, Agrawal R, Grimm KE, et al. : Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. Ann Diagn Pathol 19 : 113-116, 2015
P.310 掲載の参考文献
1) Jaffe R, Chang KL, Weiss LM, et al. : Histiocytic and dendritic cell neoplasms including Langerhans cell histiocytosis and Langerhans cell sarcoma. Hematopathology, 2nd Ed., Jaffe ES, Arber DA, Campo E, et al. eds., ELSEVIER, p969-995, 2017
2) Ye Z, Liu F, Cao Q, et al. : Interdigitating dendritic cell sarcoma of lymph node mimicking granuloma : a case report and review of the literature. Pol J Pathol 62 : 274-277, 2011
3) Weiss LM, Chan JKC : Interdigitating dendritic cell sarcoma. WHO classification of tumors of hematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, p475-476, 2017
6) O'Malley DP, Agrawal R, Grimm KE, et al. : Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. Ann Diagn Pathol 19 : 113-116, 2015
P.312 掲載の参考文献
1) Jaffe R, Chang KL, Weiss LM, et al. : Histiocytic and dendritic cell neoplasms including Langerhans cell histiocytosis and Langerhans cell sarcoma. Hematopathology, 2nd Ed., Jaffe ES, Arber DA, Campo E, et al. eds., ELSEVIER, p969-995, 2017
2) Chan JKC, Pileri SA, Fletcher CDM, et al. : Follicular dendritic cell sarcoma. WHO classification of tumours of hematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, p476-479, 2017
3) Li L, Shi YH, Guo ZJ, et al. : Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma. World J Gastroenterol 16 : 2504-2519, 2010
5) Choi PC, To KF, Lai FM, et al. : Follicular dendritic cell sarcoma of the neck : report of two cases complicated by pulmonary metastases. Cancer 89 : 664-672, 2000
7) Grogg KL, Lae ME, Kurtin PJ, et al. : Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms : report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 28 : 988-998, 2004
15) Fonseca R, Yamakawa M, Nakamura S, et al. : Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma : a review. Am J Hematol 59 : 161-167, 1998
17) Selves J, Meggetto F, Brousset P, et al. : Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol 20 : 747-753, 1996
19) Choe JY, Go H, Jeon YK, et al. : Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the spleen : a report of six cases with increased IgG4-positive plasma cells. Pathol Int 63 : 245-251, 2013
P.315 掲載の参考文献
1) Jaffe R, Chang KL, Weiss LM, et al. : Histiocytic and dendritic cell neoplasms including Langerhans cell histiocytosis and Langerhans cell sarcoma. Hematopathology, 2nd Ed., Jaffe ES, Arber DA, Campo E, et al. eds., ELSEVIER, p969-995, 2017
3) Weiss LM, Chan JKC, Fletcher CD : Fibroblastic reticular cell tumor. WHO classification of tumors of hematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, p479, 2017
P.317 掲載の参考文献
1) Brousse N, Pileri SA, Haroche J, et al. : Disseminated juvenile xanthogranuloma. WHO classification of tumors of hematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, p480, 2017
3) Jaffe R, Chang KL, Weiss LM, et al. : Histiocytic and dendritic cell neoplasms including Langerhans cell histiocytosis and Langerhans cell sarcoma. Hematopathology, 2nd Ed., Jaffe ES, Arber DA, Campo E, et al. eds., ELSEVIER, p969-995, 2017
P.319 掲載の参考文献
3) Jaffe R, Chang KL, Weiss LM, et al. : Histiocytic and dendritic cell neoplasms including Langerhans cell histiocytosis and Langerhans cell sarcoma. Hematopathology, 2nd Ed., Jaffe ES, Arber DA, Campo E, et al. eds., ELSEVIER, p969-995, 2017
4) Brousse N, Pileri SA, Haroche J, et al. : Erdheim-Chester disease. WHO classification of tumors of hematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, p481-482, 2017
5) Allen CE, Parsons DW : Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histocytic neoplastic disorders. Hematology Am Soc Hematol Educ Program 2015 : 559-564, 2015
6) Haroche J, Charlotte F, Arnaud L, et al. : High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 120 : 2700-2703, 2012
10) Arnaud L, Hervier B, Neel A, et al. : CNS involvement and treatment with interferon-α are independent prognostic factor in Erdheim-Chester disease : a multicenter survival analysis of 53 patients. Blood 117 : 2778-2782, 2011
P.321 掲載の参考文献
1) 阿部正文 : リンパ節・脾. 膠原病の病理診断マニュアル. 病理と臨 23 (臨増) : 160-170, 2005
2) Ioachim HL, Medeiros LJ : Ioachim's Lymph Node Pathology, 4th Ed., Lippincott Williams & Wilkins, 2009
3) O'Malley DP, George TI, Orazi A, et al. : Atlas of nontumor pathology, first series, fascicle 7, benign and reactive conditions of lymph node and spleen. Armed Forces Institute of Pathology, pp375-391, 2009
6) Kojima M, Nakamura N, Tsukamoto N, et al. : Atypical lymphoplasmacytic and immunoblastic proliferation of autoimmune disease. Clinicopathologic and immunohistochemical study of 9 cases. J Clin Exp Hematop 50 : 113-119, 2010
7) Kojima M, Nakamura N, Tsukamoto N, et al. : Multicentric Castleman's disease representing effusion at initial clinical presentation : clinicopathological study of 7 cases. Lupus 20 : 44-50, 2011
8) Dogan A, Gaulard P, Jaffe ES, et al. : Angioimmunoblastic T-cell lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, pp309-311, 2017
9) Suchi T, Ueda R, Suzuki H, et al. : T-zone dysplasia with hyperplastic follicles-an incipient T-cell lymphoma. Lymphoid malignancy, immunology and cytogenetics. Hanaoka M, Kadin ME, Mikata A, et al. eds., Field & Wood Medical Publishers Inc, pp155-163, 1990
10) Jeon YK, Paik JH, Park SS, et al. : Spectrum of lymph node pathology in adult onset Still's disease ; analysis of 12 patients with one follow up biopsy. J Clin Pathol 57 : 1052-1056, 2004
P.325 掲載の参考文献
P.329 掲載の参考文献
1) Lennert K, Muller-Hermelink HK : Lymphocyten und ihre Funktionsformen Morphologie, Organization und immunologische Bedeutung. Verh Anat Ges 69 : 19-62, 1975
2) Poppema S, Kaiserling E, Lennert K : Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centers-a cytohistological study. Histopathology 3 : 295-308, 1979
3) Hansmann ML, Fellbaum C, Hui PK, et al. : Progressive transformation of germinal centers with and without association to Hodgkin's disease. Am J Clin Pathol 93 : 219-226, 1990
4) Osborne BM, Butler JJ, Gresik MV : Progressive transformation of germinal centers : comparison of 23 pediatric patients to the adult population. Mod Pathol 5 : 135-140, 1992
5) Osborne BM, Butler JJ : Clinical implications of progressive transformation of germinal centers. Am J Surg Pathol 8 : 725-733, 1984
6) Burns BF, Colby TV, Dorfman RF : Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. Am J Surg Pathol 8 : 253-261, 1984
8) van den Oord JJ, de Wolf-Peeters C, Desmet VJ : Immunohistochemical analysis of progressively transformed follicular centers. Am J Clin Pathol 83 : 560-564, 1985
11) Hicks J, Flaitz C : Progressive transformation of germinal centers : review of histopathologic and clinical features. Int J Pediatr Otorhinolaryngol 65 : 195-202, 2002
12) Ferry JA, Zukerberg LR, Harris NL : Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease. Am J Surg Pathol 16 : 252-258, 1992
13) Crossley B, Heryet A, Gatter KC : Does nodular lymphocyte predominant Hodgkin's disease arise from progressively transformed germinal centres? A case report with an unusually prolonged history. Histopathology 11 : 621-630, 1987
14) Goates JJ, Kamel OW, LeBrun DP, et al. : Floral variant of follicular lymphoma. Immunological and molecular studies support a neoplastic process. Am J Surg Pathol 18 : 37-47, 1994
P.333 掲載の参考文献
1) Perrone T, De Wolf-Peeters C, Frizzera G : Inflammatory pseudotumor of lymph nodes : A distinct pattern of nodal reaction. Am J Surg Pathol 12 : 351-361, 1988
2) Davis RE, Warnke RA, Dorfman RF : Inflammatory pseudotumor of lymph nodes. Additional observations and evidence for an inflammatory etiology. Am J Surg Pathol 15 : 744-756, 1991
3) Arber DA, Kamel OW, van De Rijin M, et al. : Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol 26 : 1093-1098, 1995
4) Moran CA, Suster S, Abbondanzo SL : Inflammatory pseudotumor of lymph nodes : a study of 25 cases with emphasis on morphological heterogeneity. Hum Pathol 28 : 332-338, 1997
5) 加留部謙之輔, 菊池昌弘, 竹下盛重, 他 : リンパ節の炎症性偽腫瘍. 病理と臨 25 : 218-225, 2007
6) Ioachim HL, Medeiros LJ : Ioachim's Lymph Node Pathology, 4th Ed., Lippincott Williams & Wilkins, pp573-575, 2009
7) O'Malley DP, George TI, Orazi A, et al. : Atlas of nontumor pathology, first series, fascicle 7, benign and reactive conditions of lymph node and spleen. Armed Forces Institute of Pathology, pp528-537, 2009
8) Kojima M, Nakamura S, Shimizu K, et al. : Inflammatory pseudotumor of lymph nodes. Clinicopathologic and immunohistochemical study of 11 Japanese casses. Int J Surg Pathol 9 : 207-214, 2001
9) Chen KT : Mycobacterial spindle cell pseudotumor of lymph node. Am J Surg Pathol 16 : 276-281, 1992
11) Chan JKC, Pileri SA, Fletcher CDM, et al. : Follicular dendritic cell sarcoma. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th Ed., Swerdlow SH, Campo E, Harris NL, et al. eds., IARC Press, pp476-479, 2017
P.337 掲載の参考文献
1) Rosai J, Dorfman RF : Sinus histiocytosis with massive lymphadenopathy. Arch Pathol 87 : 63-70, 1969
2) Foucar E, Rosai J, Dorfman RF : Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) : review of the entity. Semin Diagn Pathol 7 : 19-73, 1990
3) Rosai J, Dorfman RF : Sinus histiocytosis with massive lymphadenopathy : a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 30 : 1174-1188, 1972
4) Lu D, Estalilla OC, Manning Jr JT, et al. : Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node : a report of four cases and review of the literature. Mod Pathol 13 : 414-419, 2000
5) Humble JG, Jayne WHW, Pulvertaft RJ : Biological interaction between lymphocytes and other cells. Br J Haematol 2 : 283-294, 1956
6) 社本幹博 : 血液細胞のemperipolesisとphagocytosisとの比較検討. 日臨細胞会誌 21 : 488-494, 1982
7) Kuo TT, Chen TC, Lee LY, et al. : IgG4-positive plasma cells in cutaneous Rosai-Dorfman diseases : an additional immunohistochemical feature and possible relationship to IgG4-related sclerosing disease. J Cutan Pathol 36 : 1069-1073, 2009
8) Eisen RN, Buckley PJ, Rosai J : Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Semin Diagn Pathol 7 : 74-82, 1990
9) Paulli M, Rosso R, Kindl S, et al. : Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Hum Pathol 23 : 647-654, 1992
P.341 掲載の参考文献
2) Mansoor A, Pittaluga S, Beck PL, et al. : NK-cell enteropathy : a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma : clinicopathologic features and follow-up in a unique case series. Blood 117 : 1447-1452, 2011
3) Tanaka T, Megahed N, Takata K, et al. : A case of lymphomatoid gastropathy : An indolent CD56-positive atypical gastric lymphoid proliferation, mimicking aggressive NK/T cell lymphomas. Pathol Res Pract 207 : 786-789, 2007
P.345 掲載の参考文献
1) Carr I, Daems WT : Morphology. The reticuloendothelial system. A Comprehensive Treatise. Plenum Press, pp381-605, 1980
2) Lampert IA, Pizzolo G, Thomas A, et al. : Immunohistochemical characterization of cells involved in dermatopathic lymphadenopathy. J Patho1 131 : 145-156, 1980
4) Asano S, Wakasa H : Drug-induced lymphadenopathy-two biopsy cases treated with cephem-group antibiotics for a short time-. Fukushima J Med Sci 31 : 71-78, 1985
5) Klug H : Ultrastructural differentiation of interdigitating cells in human lymph nodes. Virchows Arch B Cell Pathol 34 : 291-298, 1980
6) Veldman AJP : Histophysiology and electronmicroscopy of the immune response. Akad Profschrift Groningen : N V Bokdrukkerij Dijkstra Niemeyer, 1970
7) Asano S, Muramatsu T, Kanno H, et al. : Dermatopathic lymphadenopathy. Electronmicroscopic, enzyme-histochemical and immunohistochemical study. Acta Pathol Jpn 37 : 887-900, 1987
8) Silberberg-Sinakin I, Thorbecke GJ, Baer RL, et al. : Antigen bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 25 : 137-151, 1976
9) Muller-Hermelink HK, Schwarting H : Functional study of histiocytic and interdigitating reticulum cells from human lymphoid tissue. Virchows Arch B Cell Pathol Incl Mol Pathol 37 : 217-224, 1981
10) Watanabe S, Nakajima T, Shimosato Y, et al. : Malignant histiocytosis and Letterer-Siwe disease. Neoplasms of T-zone histiocyte with S-100 protein. Cancer 51 : 1412-1424, 1983
P.349 掲載の参考文献
1) Katzin WE, Julius CJ, Tubbs RP, et al. : Lymphoproliferative disorders associated with carbamazepine. Arch Pathol Lab Med 114 : 1244-1248, 1990
2) DiLernia V, Viglio A, Cattania M, et al. : Carbamazepine-induced CD30+ primary cutaneous anaplastic large-cell lymphoma. Arch Dermatol 137 : 675-676, 2001
3) Vittorio CC, Muglia JJ : Anticonvulsant hypersensitivity syndrome. Arch Intern Med 155 : 2285-2290, 1995
4) Hamer HM, Morris HH : Hypersensitivity syndrome to antiepileptic drugs : a review including new anticonvulsants. Cleve Clin J Med 66 : 239-245, 1999
5) Bessmertny O, Pham T : Antiepileptic hypersensitivity syndrome : clinicians beware and be aware. Curr Allergy Asthma Rep 2 : 34-39, 2002
6) Schmid D, Kluge W : Fatal toxic epidermal necrolysis following reexposure to phenytoin : a case report. Epilepsia 24 : 440-443, 1983
7) Gennis MA, Vemuri R, Burns EA, et al. : Familial occurrence of hypersensitivity to phenytoin. Am J Med 91 : 631-634, 1991
8) Shear NH, Spielberg SP : Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Inv 82 : 1826-1832, 1988
9) Schwarz UI : Clinical relevance of genetic polymorphisms in the human CYP2C9 gene. Eur J Clin Invest 33 (Suppl 2) : 23-30, 2003
12) Sinnige HA, Boender CA, Kuypers EW, et al. : Carbamazepine-induced pseudolymphoma and immune dysregulation. J Intern Med 227 : 355-358, 1990
13) Dosch HM, Jason J, Gelfand EW : Transient antibody deficiency and abnormal t-suppressor cells induced by phenytoin. N Engl J Med 306 : 406-409, 1982
14) Kruger G, Harris D, Sussman E : Effect of dilantin in mice. II. Lymphoreticular tissue atypia and neoplasia after chronic exposure. Z Krebsforsch Klin Onkol Res Clin Oncol 78 : 290-302, 1972
15) Ioachim HL, Medeiros LJ, eds. : Ioachim's Lymph Node Pathology, 4th Ed., Lippincott Williams & Wilkins, 255-258, 2009
P.353 掲載の参考文献
1) Kikuchi M, Takeshita M, Eimoto T, et al. : Histiocytic necrotizing lymphadenitis : Clinicopathologic, immunologic and HLA typing study. Lymphoid Malignancy, Immunology and Cytogenetics, Hanaoka M, Kadin ME, Mikata A, et al. eds., Field & Wood, 251-257, 1990
2) Ohshima K, Kikuchi M, Sumiyoshi Y, et al. : Proliferating cells in histiocytic necrotizing lymphadenitis. Virchows Archiv B cell Pathol Incl Mol Pathol 61 : 97-100, 1991
3) Hollingsworth HC, Peiper SC, Weiss LM, et al. : An investigation of the viral pathogenesis of Kikuchi-Fujimoto's disease. Lack of evidence for Epstein-Barr virus or human herpes type 6 as the causative agent. Arch Pathol Lab Med 118 : 134-140, 1994
4) 菊池昌弘 : 特異な組織像を呈するリンパ節炎について. 日血会誌 35 : 379-380, 1972
P.356 掲載の参考文献